AAV9-Mediated Cdk5 Inhibitory Peptide Reduces Hyperphosphorylated Tau and Inflammation and Ameliorates Behavioral Changes Caused by Overexpression of p25 in the Brain
Authors:
- 23 July 2019
- journal article
- research article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 70 (2) , 573-585
Abstract
Background: Under stress stimulation, p25 is cleaved by p35 and acts as an activator of cyclin-dependent kinase 5 (Cdk5) like p35. Unlike Cdk5/p35, which is important for brain development, aberrant activity of Cdk5/p25 plays a pathological role in nKeywords
This publication has 58 references indexed in Scilit:
- Systemic Delivery of Tyrosine-Mutant AAV Vectors Results in Robust Transduction of Neurons in Adult MiceBioMed Research International, 2013
- Direct Lineage Conversion of Terminally Differentiated Hepatocytes to Functional NeuronsCell Stem Cell, 2011
- Conversion of Mouse and Human Fibroblasts into Functional Spinal Motor NeuronsCell Stem Cell, 2011
- Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer’s disease brainTranslational Psychiatry, 2011
- Induction of human neuronal cells by defined transcription factorsNature, 2011
- A 24-Residue Peptide (p5), Derived from p35, the Cdk5 Neuronal Activator, Specifically Inhibits Cdk5-p25 Hyperactivity and Tau HyperphosphorylationJournal of Biological Chemistry, 2010
- Structural and Dynamic Determinants of Ligand Binding and Regulation of Cyclin-Dependent Kinase 5 by Pathological Activator p25 and Inhibitory Peptide CIPJournal of Molecular Biology, 2010
- LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 miceJournal of Neuroinflammation, 2010
- Neurodegeneration and Neuroinflammation in cdk5/p25-Inducible MiceThe American Journal of Pathology, 2008
- PKA modulates GSK‐3β‐ and cdk5‐catalyzed phosphorylation of tau in site‐ and kinase‐specific mannersFEBS Letters, 2006